Key statistics
As of last trade Harvard Bioscience Inc (HBI:DUS) traded at 2.24, 9.80% above its 52-week low of 2.04, set on Oct 11, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.34 |
---|---|
High | 2.38 |
Low | 2.24 |
Bid | 2.28 |
Offer | 2.36 |
Previous close | 2.28 |
Average volume | 0.00 |
---|---|
Shares outstanding | 43.61m |
Free float | 40.22m |
P/E (TTM) | -- |
Market cap | 112.08m USD |
EPS (TTM) | -0.2471 USD |
Data delayed at least 15 minutes, as of Nov 11 2024 18:30 GMT.
More ▼
- Harvard Bioscience Announces Third Quarter 2024 Financial Results
- Harvard Bioscience Schedules Third Quarter 2024 Earnings Conference Call for November 7, 2024 at 8:00 AM ET
- Harvard Bioscience to Showcase Innovative Technologies at Society for Neuroscience (SfN) Annual Meeting 2024
- Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Safety Pharmacology Society Annual Meeting
- Harvard Bioscience Announces Second Quarter 2024 Financial Results
- Harvard Bioscience Schedules Second Quarter 2024 Earnings Conference Call for August 8, 2024 at 10:00 AM ET
- Harvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024
- Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024
- Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference
- Harvard Bioscience Announces First Quarter 2024 Financial Results
More ▼